{"entity":{"type":"insider","cik":"0001503062","url":"/insider/0001503062","json_url":"/insider/0001503062.json","name":"Patel Sunil","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":32,"n_filings":13,"first":"2011-02-17","last":"2022-11-10","span_basis":"filed_date"},"name_variants":[{"name":"Patel Sunil","source":"filing","n_filings":13,"first_seen":"2011-02-17","last_seen":"2022-11-10"}],"transactions":[{"id":6533646,"accession":"0000899243-22-035565","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035565","line_url":"/filing/0000899243-22-035565#line-1","is_derivative":false,"issuer_cik":"0001503062","issuer_name":"OmniAb, Inc.","issuer_ticker":"OABI","issuer_name_source":null,"issuer_url":"/issuer/0001503062","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43000.0,"shares_display":"43,000","price_per_share":2.77,"price_display":"2.77","price_state":"stated","total_value":119110.0,"total_display":"119,110.00","total_whole":"119,110","shares_owned_after":215512.0,"shares_owned_after_display":"215,512","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-09","filed_date":"2022-11-10","scope":"insider"},{"id":2131915,"accession":"0000886163-20-000118","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-20-000118","line_url":"/filing/0000886163-20-000118#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":82.52,"price_display":"82.52","price_state":"stated","total_value":82520.0,"total_display":"82,520.00","total_whole":"82,520","shares_owned_after":28190.0,"shares_owned_after_display":"28,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-02","filed_date":"2020-11-04","scope":"insider"},{"id":7830076,"accession":"0000886163-19-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-19-000136","line_url":"/filing/0000886163-19-000136#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":95.98,"price_display":"95.98","price_state":"stated","total_value":95980.0,"total_display":"95,980.00","total_whole":"95,980","shares_owned_after":26359.0,"shares_owned_after_display":"26,359","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-02","filed_date":"2019-08-05","scope":"insider"},{"id":6618519,"accession":"0000886163-18-000120","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000886163-18-000120","line_url":"/filing/0000886163-18-000120#line-5","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42287.0,"shares_display":"42,287","price_per_share":240.0456,"price_display":"240.05","price_state":"stated","total_value":10150808.2872,"total_display":"10,150,808.29","total_whole":"10,150,808","shares_owned_after":24524.0,"shares_owned_after_display":"24,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-16","filed_date":"2018-08-17","scope":"insider"},{"id":5298141,"accession":"0001140361-17-038568","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-038568","line_url":"/filing/0001140361-17-038568","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1248.0,"shares_display":"1,248","price_per_share":4.242839423076923,"price_display":"4.24","price_state":"stated","total_value":5295.0636,"total_display":"5,295.06","total_whole":"5,295","shares_owned_after":68336.0,"shares_owned_after_display":"68,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-10","filed_date":"2017-10-12","scope":"insider","n_lines":2},{"id":5222757,"accession":"0001140361-17-015048","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-17-015048","line_url":"/filing/0001140361-17-015048","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5754.0,"shares_display":"5,754","price_per_share":9.056825703858186,"price_display":"9.06","price_state":"stated","total_value":52112.9751,"total_display":"52,112.98","total_whole":"52,113","shares_owned_after":24584.0,"shares_owned_after_display":"24,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-04","filed_date":"2017-04-05","scope":"insider","n_lines":2},{"id":2105899,"accession":"0001140361-16-047334","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-16-047334","line_url":"/filing/0001140361-16-047334#line-3","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":21.33,"price_display":"21.33","price_state":"stated","total_value":21.33,"total_display":"21.33","total_whole":"21","shares_owned_after":17838.0,"shares_owned_after_display":"17,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-07","filed_date":"2016-01-08","scope":"insider"},{"id":2105896,"accession":"0001140361-16-047334","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-16-047334","line_url":"/filing/0001140361-16-047334","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2161.0,"shares_display":"2,161","price_per_share":22.27990638593244,"price_display":"22.28","price_state":"stated","total_value":48146.8777,"total_display":"48,146.88","total_whole":"48,147","shares_owned_after":17908.0,"shares_owned_after_display":"17,908","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-01-06","filed_date":"2016-01-08","scope":"insider","n_lines":2},{"id":8883805,"accession":"0001140361-15-012986","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-15-012986","line_url":"/filing/0001140361-15-012986#line-4","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14665.0,"shares_display":"14,665","price_per_share":27.8584,"price_display":"27.86","price_state":"stated","total_value":408543.436,"total_display":"408,543.44","total_whole":"408,543","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-20","filed_date":"2015-03-23","scope":"insider"},{"id":8883801,"accession":"0001140361-15-012986","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-012986","line_url":"/filing/0001140361-15-012986#line-2","is_derivative":false,"issuer_cik":"0001302573","issuer_name":"OncoMed Pharmaceuticals Inc","issuer_ticker":"OMED","issuer_name_source":null,"issuer_url":"/issuer/0001302573","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3335.0,"shares_display":"3,335","price_per_share":27.3422,"price_display":"27.34","price_state":"stated","total_value":91186.237,"total_display":"91,186.24","total_whole":"91,186","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-23","scope":"insider"},{"id":8627286,"accession":"0000886163-15-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000886163-15-000038","line_url":"/filing/0000886163-15-000038#line-1","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4591.0,"shares_display":"4,591","price_per_share":74.42,"price_display":"74.42","price_state":"stated","total_value":341662.22,"total_display":"341,662.22","total_whole":"341,662","shares_owned_after":37100.0,"shares_owned_after_display":"37,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-19","filed_date":"2015-03-20","scope":"insider"},{"id":3149697,"accession":"0000886163-12-000027","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000886163-12-000027","line_url":"/filing/0000886163-12-000027","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":11.380229333333334,"price_display":"11.38","price_state":"stated","total_value":17070.344,"total_display":"17,070.34","total_whole":"17,070","shares_owned_after":29705.0,"shares_owned_after_display":"29,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-23","filed_date":"2012-05-24","scope":"insider","n_lines":5},{"id":9156171,"accession":"0000886163-11-000061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000886163-11-000061","line_url":"/filing/0000886163-11-000061","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGNDD","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":11.10968,"price_display":"11.11","price_state":"stated","total_value":27774.2,"total_display":"27,774.20","total_whole":"27,774","shares_owned_after":28205.0,"shares_owned_after_display":"28,205","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-11-10","filed_date":"2011-11-10","scope":"insider","n_lines":2},{"id":9068672,"accession":"0000886163-11-000057","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000886163-11-000057","line_url":"/filing/0000886163-11-000057","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":10.740988,"price_display":"10.74","price_state":"stated","total_value":53704.94,"total_display":"53,704.94","total_whole":"53,705","shares_owned_after":25705.0,"shares_owned_after_display":"25,705","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-10","filed_date":"2011-08-11","scope":"insider","n_lines":6},{"id":8981243,"accession":"0000886163-11-000007","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000886163-11-000007","line_url":"/filing/0000886163-11-000007","is_derivative":false,"issuer_cik":"0000886163","issuer_name":"LIGAND PHARMACEUTICALS INC","issuer_ticker":"LGND","issuer_name_source":null,"issuer_url":"/issuer/0000886163","owner_cik":"0001503062","owner_name":"Patel Sunil","owner_display_name":"Patel Sunil","owner_url":"/insider/0001503062","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":9.2173749,"price_display":"9.22","price_state":"stated","total_value":92173.749,"total_display":"92,173.75","total_whole":"92,174","shares_owned_after":9222.0,"shares_owned_after_display":"9,222","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-02-16","filed_date":"2011-02-17","scope":"insider","n_lines":5}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":32,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":21,"open_market":true},{"code":"S","label":"Open-market sale","n":11,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":32},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001846253","name":"OmniAb, Inc.","url":"/issuer/0001846253","role":"Director","n_filings":1,"first_seen":"2022-11-10","last_seen":"2022-11-10"},{"type":"issuer","type_label":"ISSUER","cik":"0000886163","name":"LIGAND PHARMACEUTICALS INC","url":"/issuer/0000886163","role":"Director","n_filings":8,"first_seen":"2011-02-17","last_seen":"2020-11-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001302573","name":"OncoMed Pharmaceuticals Inc","url":"/issuer/0001302573","role":"Officer","n_filings":4,"first_seen":"2015-03-23","last_seen":"2017-10-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001503062","retrieved_at":"2026-08-23T09:30:55+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}